Stanford researchers have identified a specific protein - CD47- which is upregulated in all cancer cells that aims to trick the immune system into not attacking them. By developing an antibody that blocks the expression of CD47 in all cancer cells, researchers were successful in catalyzing the immune system in killing tumors of the lung, brain, liver, and other vital organs. “We showed that even after the tumor has taken hold, the antibody can either cure the tumor or slow its growth and prevent metastasis,” said biologist Irving Weissman of the Stanford University School of Medicine.
RSS Feed